29: Drug Safety After Approval: A Conversation with FDA’s Gerald Dal Pan, MD

Sally Greenberg speaks with Gerald Dal Pan, M.D., Director of the FDA’s Office of Surveillance and Epidemiology, to explain how the FDA identifies drug safety signals, responds to emerging safety concerns and adherence challenges, and ensures ongoing protection for patients.